CSL Stock

CSL Debt 2024

CSL Debt

10,526 USD

Ticker

CSL.AX

ISIN

AU000000CSL8

WKN

890952

In 2024, CSL's total debt was 10,526 USD, a -193.86% change from the -11,215 USD total debt recorded in the previous year.

CSL Aktienanalyse

What does CSL do?

CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding CSL's Debt Structure

CSL's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing CSL's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to CSL’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in CSL’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about CSL stock

What is the debt of CSL this year?

CSL has a debt level of 10,526 USD this year.

What was the debt of CSL compared to the previous year?

The debt of CSL has increased by -193.86% compared to the previous year dropped.

What are the consequences of high debt for investors in CSL?

High debt can pose a risk for investors of CSL, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of CSL?

Low debt means that CSL has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from CSL affect the company?

An increase in debt of CSL can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of CSL affect the company?

A reduction in debt of CSL can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of CSL?

Some factors that can influence the debt of CSL include investments, acquisitions, operating costs, and revenue development.

Why are the debts of CSL so important for investors?

The debts of CSL are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can CSL take to change the debt?

To change the debt, CSL can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does CSL pay?

Over the past 12 months, CSL paid a dividend of 3.97 USD . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, CSL is expected to pay a dividend of 4.19 USD.

What is the dividend yield of CSL?

The current dividend yield of CSL is 2.17 %.

When does CSL pay dividends?

CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of CSL?

CSL paid dividends every year for the past 26 years.

What is the dividend of CSL?

For the upcoming 12 months, dividends amounting to 4.19 USD are expected. This corresponds to a dividend yield of 2.29 %.

In which sector is CSL located?

CSL is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSL from 10/2/2024 amounting to 2.175 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did CSL pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of CSL in the year 2023?

In the year 2023, CSL distributed 3.715 USD as dividends.

In which currency does CSL pay out the dividend?

The dividends of CSL are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The CSL stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von CSL

Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.